Market capitalization | $9.32b |
Enterprise Value | $8.52b |
P/E (TTM) P/E ratio | 57.41 |
EV/FCF (TTM) EV/FCF | 39.21 |
EV/Sales (TTM) EV/Sales | 16.49 |
P/S ratio (TTM) P/S ratio | 18.03 |
P/B ratio (TTM) P/B ratio | 9.70 |
Revenue growth (TTM) Revenue growth | 15.29% |
Revenue (TTM) Revenue | $516.85m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
18 Analysts have issued a Doximity forecast:
18 Analysts have issued a Doximity forecast:
Sep '24 |
+/-
%
|
||
Revenue | 517 517 |
15%
15%
|
|
Gross Profit | 465 465 |
18%
18%
|
|
EBITDA | 213 213 |
36%
36%
|
EBIT (Operating Income) EBIT | 203 203 |
41%
41%
|
Net Profit | 174 174 |
41%
41%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Doximity, Inc. operates an online platform for medical professionals. It's cloud-based software has the ability to enable the users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. The company was founded by Konstantin Guericke, Nate Gross and Jeffrey A. Tangney in April 16, 2010 and is headquartered in San Francisco, CA.
Head office | United States |
CEO | Jeffrey Tangney |
Employees | 827 |
Founded | 2010 |
Website | www.doximity.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.